
Oluwatosin A. Ogunbiyi
Examiner (ID: 17664, Phone: (571)272-9939 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1148 |
| Issued Applications | 603 |
| Pending Applications | 160 |
| Abandoned Applications | 405 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19572131
[patent_doc_number] => 20240376423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => MICROORGANISMS DISPLAYING VIRAL DECOY RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 18/293016
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293016 | MICROORGANISMS DISPLAYING VIRAL DECOY RECEPTORS | Jul 5, 2022 | Pending |
Array
(
[id] => 19311562
[patent_doc_number] => 12037365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Peptides and their use in diagnosis
[patent_app_type] => utility
[patent_app_number] => 17/852797
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9248
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852797 | Peptides and their use in diagnosis | Jun 28, 2022 | Issued |
Array
(
[id] => 19477472
[patent_doc_number] => 20240325514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
[patent_app_type] => utility
[patent_app_number] => 18/293380
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293380 | A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES | Jun 28, 2022 | Pending |
Array
(
[id] => 19457881
[patent_doc_number] => 12098361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Attenuated
[patent_app_type] => utility
[patent_app_number] => 17/851692
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 4
[patent_no_of_words] => 10312
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851692 | Attenuated | Jun 27, 2022 | Issued |
Array
(
[id] => 18389865
[patent_doc_number] => 20230158083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/847336
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/847336 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Jun 22, 2022 | Abandoned |
Array
(
[id] => 17897322
[patent_doc_number] => 20220306984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHOD FOR SELECTION OF AGENTS INFLUENCING INTESTINAL MOTILITY DISORDERS AND PAIN
[patent_app_type] => utility
[patent_app_number] => 17/840923
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840923 | METHOD FOR SELECTION OF AGENTS INFLUENCING INTESTINAL MOTILITY DISORDERS AND PAIN | Jun 14, 2022 | Abandoned |
Array
(
[id] => 18938200
[patent_doc_number] => 20240033339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => STREPTOCOCCUS SUIS (S. SUIS) VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/272371
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272371
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272371 | None | Jun 9, 2022 | Issued |
Array
(
[id] => 19909263
[patent_doc_number] => 12285449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Fermented milk for improving autonomic nervous function
[patent_app_type] => utility
[patent_app_number] => 17/828772
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/828772 | Fermented milk for improving autonomic nervous function | May 30, 2022 | Issued |
Array
(
[id] => 18127971
[patent_doc_number] => 11554167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer
[patent_app_type] => utility
[patent_app_number] => 17/747253
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13179
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747253 | Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer | May 17, 2022 | Issued |
Array
(
[id] => 17851884
[patent_doc_number] => 20220281926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CELL-TARGETING MOLECULES COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/746106
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 141060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/746106 | DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CELL-TARGETING MOLECULES COMPRISING THE SAME | May 16, 2022 | Pending |
Array
(
[id] => 19310480
[patent_doc_number] => 12036274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Recombinant MPT protein derived from MPT63 and MPT64 and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/736708
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 10961
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736708 | Recombinant MPT protein derived from MPT63 and MPT64 and use thereof | May 3, 2022 | Issued |
Array
(
[id] => 20881351
[patent_doc_number] => 12697370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-04
[patent_title] => PSG1 for use in the treatment of osteoarthritis
[patent_app_type] => utility
[patent_app_number] => 18/555431
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 10536
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555431 | PSG1 FOR USE IN THE TREATMENT OF OSTEOARTHRITIS | Apr 13, 2022 | Pending |
Array
(
[id] => 19915217
[patent_doc_number] => 12290563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Production of
[patent_app_type] => utility
[patent_app_number] => 17/710116
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10827
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710116 | Production of | Mar 30, 2022 | Issued |
Array
(
[id] => 20218660
[patent_doc_number] => 20250281591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/551830
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551830
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551830 | STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS | Mar 30, 2022 | Pending |
Array
(
[id] => 17687721
[patent_doc_number] => 20220195013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => MULTI-EPITOPIC CONSTRUCT
[patent_app_type] => utility
[patent_app_number] => 17/693785
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693785 | MULTI-EPITOPIC CONSTRUCT | Mar 13, 2022 | Abandoned |
Array
(
[id] => 20206315
[patent_doc_number] => 20250276035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => ANTIBACTERIAL POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/549364
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549364
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549364 | ANTIBACTERIAL POLYPEPTIDES | Mar 8, 2022 | Pending |
Array
(
[id] => 19156092
[patent_doc_number] => 20240148799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => COMPOSITION AND AMELIORATING AGENT HAVING INFLAMMATION REDUCING EFFECT
[patent_app_type] => utility
[patent_app_number] => 18/549804
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549804
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549804 | COMPOSITION AND AMELIORATING AGENT HAVING INFLAMMATION REDUCING EFFECT | Mar 7, 2022 | Abandoned |
Array
(
[id] => 19554949
[patent_doc_number] => 20240366741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/550036
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550036 | NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF | Mar 7, 2022 | Pending |
Array
(
[id] => 18003601
[patent_doc_number] => 20220362367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS)-BASED STAPHYLOCOCCUS AUREUS VACCINE, IMMUNOGENIC COMPOSITION, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/688780
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17688780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/688780 | MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS)-BASED STAPHYLOCOCCUS AUREUS VACCINE, IMMUNOGENIC COMPOSITION, AND USES THEREOF | Mar 6, 2022 | Pending |
Array
(
[id] => 17673058
[patent_doc_number] => 20220186225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => COMPOUNDS FOR DETECTING AND TREATING MYCOPLASMA HYOPNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/685727
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685727 | Compounds for detecting and treating | Mar 2, 2022 | Issued |